Drug Target Review

JULY 7, 2025

The shift is not only ethical but also pragmatic: the agency cited goals such as lowering research and development costs, accelerating time to market and improving translational relevance between preclinical and clinical outcomes. Guide for the Care and Use of Laboratory Animals. Alternatives to Laboratory Animals , 50(3).

Drug Research

Drug Target Review

JUNE 19, 2025

Still, Bazan says “Vertex’s work has been so important for the pain field – to get eyes on the large market size that matches the significant societal and clinical need for pain innovation.” SRP-001 has already moved beyond the laboratory. Unlike the newly approved NaV1.8 Crucially, it is not associated with abuse potential.

Clinical Trials

The Pharma Data

JUNE 13, 2025

The two companies have signed a Memorandum of Understanding (MoU) to provide comprehensive support and resources to Japanese drug-discovery startups, helping them bring their innovations from laboratory benches toward eventual global delivery of new medicines.

Research

Drug Target Review

MAY 14, 2025

For example, in supply chain, when launching a new product to market with limited sales data, domain expertise becomes critical. What makes this an exciting time is that laboratory automation technology has matured significantly in recent years. These two halves of the problem are coming together.

Drugs

Alta Sciences

NOVEMBER 13, 2024

Their three state-of-the-art bioanalytical laboratories feature mirrored operations and uniform protocols to maintain consistency and quality across client projects, ensuring reliable, high-quality data regardless of location. Lynne Le Sauteur, Vice President of Laboratory Sciences at Altasciences.

Clinical Pharmacology

The Premier Consulting Blog

OCTOBER 30, 2024

The I-TEAM Hub is a laboratory space specifically designed for FDA staff to have hands-on experience with various advanced technologies on which they would advise, e.g., AI/machine learning, 3D printing, etc. To support this, the Innovative Technologies and Advanced Manufacturing Hub (I-TEAM Hub) was created.

FDA

Drug Target Review

JUNE 19, 2025

This focus has allowed the company to serve not only large-scale industry users, but also academic groups and researchers in emerging markets who may otherwise lack access to advanced automation. .” Opentrons has prioritised accessibility in its system design, creating modular, user-friendly platforms.

Analytical Chemistry

The Pharma Data

JUNE 9, 2025

Li, President of Merck Research Laboratories, underscored the importance of this approval for the company’s pediatric infectious disease portfolio. The simplified dosing, long duration of protection, and compelling clinical results position ENFLONSIA as a competitive new option in a market where innovation has been limited for years.

FDA Approval

Codon

JULY 28, 2025

For the former, clinicians extract a patient’s cells, engineer them in a laboratory, and then infuse them back into the body. To better understand the various tradeoffs at work, then, let’s examine the various gene delivery vehicles both on the market and under development. This article includes a poster. Join Asimov Press.

Immune Response

The Pharma Data

JUNE 24, 2025

This expanded partnership reflects Bayer’s ongoing commitment to strengthening its presence in China—home to the world’s second-largest pharmaceutical market—and underscores its strategic vision to bolster healthcare innovation through cross-sector collaboration.

Pharma R&D

Alta Sciences

JULY 23, 2025

BD Biosciences showcased their FACSDiscover A8 TM as the first provider on the market to combine live-cell imaging with spectral flow cytometry—a useful analytical tool for any institution performing innovative science. INSIGHTFUL CYTOMETRY WORKSHOPS Spectral cytometry continues to evolve.

International

The Pharma Data

JUNE 26, 2025

The campus design is anchored by a Z-shaped laboratory and R&D office complex that forms a prominent urban frontage—serving as both a gateway to innovation and a symbolic link between science and the broader community.

Laboratories

Drug Target Review

JUNE 5, 2025

Dr Aaron Haubner, Senior Manager of North America Medical Affairs and Market Access at Terumo Blood and Cell Technologies , reveals that while promising new treatments emerge, urgent partnerships are needed to ensure this essential blood therapy reaches the patients who need it most.

Disease

LifeSciVC

JUNE 12, 2025

Josh’s work at the Marine Biological Laboratory unlocked the potential of utilizing an endogenous protein to make a single alphabet change on RNA (RNA editing), a process that was precise, reversible and had druglike characteristics. (Academic specializing in RNA editing). These are exciting times for us at Korro, and the field in general!

RNA

Drug Target Review

JUNE 13, 2025

This pivotal moment prompted Liz to complete a degree in veterinary medicine, specialising in laboratory animal medicine. The job market might not have your perfect role yet – but with focus and effort, you can help create it.” That sparked my interest in animal welfare and ethics.

Research

Codon

APRIL 14, 2025

Many CROs operate in small, captive markets with high switching costs. Inside the FutureHouse laboratory. Better infrastructure and services would accelerate the entire field from academic research to lucrative therapeutic development. Weak incentives for operational excellence compound such talent challenges. Photo by Xiaofan Fang.

Protein Expression

Drug Patent Watch

JANUARY 9, 2025

Enter the Contract Development and Manufacturing Organization (CDMO) a lifeline for many startups looking to bring their innovative therapies to market. In 2017, small and medium-sized biotech companies accounted for 51% of FDA market approvals, while large pharma companies were the originators in only 28% of approvals[4].

Compliance

Conversations in Drug Development Trends

NOVEMBER 12, 2024

Modifying and expanding the cells in a GMP laboratory. While many market-approved cell therapies available today are autologous products, allogeneic interventions are growing more common. At a high level, the process involves: Collecting cells from the patient (autologous) or processing healthy donor cells (allogeneic).

Therapies

Reprocell

NOVEMBER 14, 2024

To address the issues of time and cost, pharmaceutical companies rely on central laboratories (CLs) for consistency, organization, and efficiency during the clinical trial phase, which is essential for drug approval.

Marketing

The Pharma Data

JUNE 13, 2025

Currently, marketing authorization applications for KEYTRUDA, based on the results from KEYNOTE-689, are under review by health authorities in Israel, Canada, Australia, Singapore, Brazil, and Switzerland. This application was reviewed under Project Orbis, a collaborative framework by the FDA’s Oncology Center of Excellence.

FDA Approval

Codon

NOVEMBER 1, 2024

” Nobody really knows without trying it out in the laboratory. For one, life itself grows and develops slowly, and the many steps required to “do” biological research in the laboratory are often tedious and manual. Even in vitro experiments — or those done in the laboratory — are relatively slow because E.

DNA

Translation

JUNE 11, 2025

market preparation. In Japan, Bayer’s Collaborate to Cure Hub focuses on connecting domestic innovation with global opportunity through structured mentoring and business development.

Science

BioPharma Drive: Drug Pricing

JUNE 26, 2025

Published June 26, 2025 Ned Pagliarulo Lead Editor post share post print email license An Incyte researcher works in a laboratory. and sold [Karuna],” wrote RBC Capital Markets analyst Brian Abrahams, in a note to clients. On June 26, 2025, the company announced the replacement of longtime CEO Hervé Hoppenot with Bill Meury.

Therapies

Codon

JULY 14, 2025

Eichengrün’s laboratory at Bayer. In this article, Eichengrün stated that he was appointed, in 1895, to establish and manage a pharmaceutical laboratory at Bayer. Drugs developed in Eichengrün’s laboratory were tested at Bayer’s pharmacological laboratory, led by Heinrich Dreser.

Treatment

FDA Law Blog: Drug Discovery

JANUARY 12, 2025

This may also help to derisk parallel product development amongst multiple products for the same condition, where another product in development may gain traditional approval or another product already on the market under accelerated approval may confirm clinical benefit prior to completion of clinical trials to support accelerated approval (e.g.,

FDA

FDA Law Blog: Biosimilars

FEBRUARY 20, 2025

Gibbs The multi-decade battle over FDAs power to regulate Laboratory Developed Tests (LDTs) had its day in court earlier this week. As our readers will recall, the LDT rule will bring, by FDAs estimates, hundreds of thousands of laboratory tests under FDAs regulatory purview. Mullen & Jeffrey N.

Laboratories

Codon

JULY 10, 2025

How Model Organisms Arrived in the Lab For the last 60 years, the roundworm Caenorhabditis elegans has served as a premier laboratory model. Why do the 96-well plates used in molecular biology laboratories consist of 96 wells instead of 100 or 200? What are the bottlenecks of tree engineering, and what would overcoming them solve?

Engineering

Conversations in Drug Development Trends

MAY 15, 2025

This blog highlights some of the key themes discussed in our white paper on the application process, From Concept to Market: The Strategic Role of an IND in Drug DevelopmentMoving Beyond “May Proceed.” Have you considered the multiple associated benefits and implications in the context of your novel drug development plan?

Clinical Trials

The Pharma Data

JUNE 27, 2025

His remarks reflect ongoing frustrations from the global health community over the restricted access to raw data, early case records, market inventories, and laboratory biosafety audits that are essential to a comprehensive analysis of the virus’s origin.

Laboratories

Drug Discovery Today

AUGUST 10, 2020

Further easing of import restrictions by the Government will provide faster access to patients prescribed cannabis-based medicines — and is the removal of yet another barrier in a market expected to grow in the coming years.

Marketing

The Connected Lab

MAY 4, 2022

Here, we look at how ongoing advances in laboratory informatics solutions will help organizations ease the path to this future landscape. Advances in laboratory informatics solutions are easing the path to Pharma 4.0.

Laboratory Informatics

PPD

OCTOBER 18, 2023

1 With this growth comes increased demands for laboratory services at all steps across the development process. Access to a laboratory partner that already possesses the equipment, knowledge and personnel can save time and money. Stay ahead of the curve with a great GMP/CMC contract laboratory partner.

Laboratories

Alta Sciences

OCTOBER 31, 2023

Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia, Missouri pmjackson Tue, 10/31/2023 - 16:08 Laval, Québec, October 31, 2023 – Altasciences is pleased to announce the completion of its laboratory facilities in Columbia, MO. This is Altasciences’ third purpose-built laboratory.

Laboratories

Precision for Medicine

DECEMBER 1, 2023

December 1, 2023 — Precision for Medicine, the first global biomarker-driven clinical research organization, is the recipient of a new accreditation from The College of American Pathologists (CAP) for its tissue and histopathology laboratory in Winston-Salem, North Carolina. Winston-Salem, Nc.,

Laboratories

Elrig

JUNE 15, 2023

We're Hiring - Marketing & Sales Assistant We’re Hiring! We are looking for an Events Marketing & Inside Sales Assistant to support the Marketing Manager, Business Development and Operations Team in all ELRIG’s marketing and sales activities, as well as day to day implementation of marketing tasks.

Marketing

The Pharma Data

OCTOBER 27, 2020

HYDERABAD, India–( BUSINESS WIRE )– Dr. Reddy’s Laboratories Ltd. About Dr. Reddy’s : Dr. Reddy’s Laboratories Ltd. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, India, Russia & CIS countries, and Europe. 28, 2020 10:09 UTC. KMP* – Key Managerial Personnel.

Laboratories

thought leadership

SEPTEMBER 7, 2023

Developing in vitro diagnostic tests, laboratory-developed tests, medical devices, or therapeutics is complex and requires careful consideration of various factors. In this blog post, we will explore the value of market access analysis and its role in the development of medical products.

Marketing